{"id":5831,"date":"2021-08-09T13:00:39","date_gmt":"2021-08-09T11:00:39","guid":{"rendered":"https:\/\/pikralida.eu\/publication-a-pharmaceutical-strategy-for-europe\/"},"modified":"2021-08-13T15:18:22","modified_gmt":"2021-08-13T13:18:22","slug":"publication-a-pharmaceutical-strategy-for-europe","status":"publish","type":"post","link":"https:\/\/pikralida.eu\/en\/publication-a-pharmaceutical-strategy-for-europe\/","title":{"rendered":"Publication &#8220;A pharmaceutical strategy for Europe&#8221;"},"content":{"rendered":"<style>.wp-block-kadence-advancedheading.kt-adv-heading_dc0ccf-8b, .wp-block-kadence-advancedheading.kt-adv-heading_dc0ccf-8b[data-kb-block=\"kb-adv-heading_dc0ccf-8b\"]{font-size:20px;font-style:normal;}.wp-block-kadence-advancedheading.kt-adv-heading_dc0ccf-8b mark.kt-highlight, .wp-block-kadence-advancedheading.kt-adv-heading_dc0ccf-8b[data-kb-block=\"kb-adv-heading_dc0ccf-8b\"] mark.kt-highlight{font-style:normal;color:#f76a0c;-webkit-box-decoration-break:clone;box-decoration-break:clone;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;}<\/style>\n<h2 class=\"kt-adv-heading_dc0ccf-8b wp-block-kadence-advancedheading\" data-kb-block=\"kb-adv-heading_dc0ccf-8b\">The latest issue of the \u201cNAUKA\u201d (SCIENCE) quarterly published by the Polish Academy of Sciences features a publication titled \u201eStrategia Farmaceutyczna dla Europy: czy synteza substancji czynnych mo\u017ce sta\u0107 si\u0119 polsk\u0105 specjalno\u015bci\u0105?\u201d on a pharmaceutical strategy for Europe, with the central question being whether the synthesis of active ingredients may become a Polish speciality.<\/h2>\n\n\n\n<p> The article is co-authored by dr Anna Krause, Research Director at Pikralida sp. z o.o., who, as a specialist, was appointed a member of the <a href=\"https:\/\/ktinol.pan.pl\/index.php?lang=pl\">Committee on Therapeutics and Pharmaceuticals Science of the Polish Academy of Sciences<\/a>.<br>Here, you can read the <a href=\"https:\/\/journals.pan.pl\/Content\/119203\/PDF\/N%23321-03-Strategia-farmaceutyczna.pdf\">study<\/a>, which is \u201ean attempt at a synthesis of the current situation and a guideline pointing towards possible courses of action. First and foremost, however, it is intended to activate the scientific community and trigger a substantive discussion on the development of synthesis of active ingredients in Poland. Given the extensiveness of the issue at hand, the authors have focused on low-molecular compounds, the domestic perspective, and on considering the environmental aspects when it comes to the synthesis of active ingredients.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Being whether the synthesis of active ingredients may become a Polish speciality?<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[38],"tags":[],"class_list":["post-5831","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/pikralida.eu\/en\/wp-json\/wp\/v2\/posts\/5831","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pikralida.eu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pikralida.eu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pikralida.eu\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pikralida.eu\/en\/wp-json\/wp\/v2\/comments?post=5831"}],"version-history":[{"count":0,"href":"https:\/\/pikralida.eu\/en\/wp-json\/wp\/v2\/posts\/5831\/revisions"}],"wp:attachment":[{"href":"https:\/\/pikralida.eu\/en\/wp-json\/wp\/v2\/media?parent=5831"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pikralida.eu\/en\/wp-json\/wp\/v2\/categories?post=5831"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pikralida.eu\/en\/wp-json\/wp\/v2\/tags?post=5831"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}